ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days

ClinicalTrials.gov ID: NCT02547805

Public ClinicalTrials.gov record NCT02547805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 23, 2026, 6:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of ALLN-177 Treatment Over 28 Days in Patients With Secondary Hyperoxaluria and Kidney Stones

Study identification

NCT ID
NCT02547805
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allena Pharmaceuticals
Industry
Enrollment
66 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2015
Primary completion
Dec 31, 2016
Completion
Dec 31, 2016
Last update posted
Jan 18, 2017

2015 – 2017

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Mayo Clinica Arizona Pheonix Arizona 85054
Urological Associates of Southern Arizona, PC Tuscon Arizona 85741
Applied Research Center of Arkansas, Inc. Little Rock Arkansas 72212
South Florida Medical Research, LLC Aventura Florida 33180
Atlantic Urological Associates Daytona Beach Florida 32114
Clinical Research Center of Florida Pompano Beach Florida 33060
Idaho Urological Institute Meridian Idaho 83642
IU Health Physicians Urology Indianapolis Indiana 46202
Regional Urology, LLC Shreveport Louisiana 71106
Massachusetts General Hospital Boston Massachusetts 02114
Mayo Clinic Department of Medicine Clinical Trials Unit Rochester Minnesota 555905
Delaware Valley Urology, LLC Voorhees Township New Jersey 08043
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601
Associated Urologists of North Carolina Raleigh North Carolina 27612
Coastal Urology Wilmington North Carolina 28401
Tristate Urologic Services PSC INC. DBA The Urology group Cincinnati, OH Ohio 45212
Clinical Research Solutions, LLC Middleburg Heights Ohio 44130
Omega Medical Research Warwick Rhode Island 02886
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Urology Clinics of North Texas PLLC Dallas Texas 75231
Urology of Virginia Virginia Beach Virginia 23462
Integrity Medical Research Mountlake Terrace Washington 98043

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02547805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2017 · Synced Apr 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02547805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →